Guggenheim Maintains Buy on BeiGene, Raises Price Target to $228

Guggenheim maintains BeiGene (NASDAQ:BGNE) with a Buy and raises the price target from $205 to $228.

Benzinga · 11/15/2019 12:52

Guggenheim maintains BeiGene (NASDAQ:BGNE) with a Buy and raises the price target from $205 to $228.